Effect of CSII and CGM on Progression of Late Diabetic Complications

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Insulin pump therapy (CSII) plus continuous glucose monitoring (CGM)

Randomization to 12 months with CSII plus CGM

OTHER

Multiple daily insulin injections (MDI)

Randomization12 months therapy with MDI

Trial Locations (1)

2820

Steno Diabetes Center, Gentofte Municipality

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Steen Andersen

OTHER